Related Experiment Video
Updated: Jul 4, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia
Natalja Fjodorova1, Marjana Novich, Marjan Vrachko
1National Institute of Chemistry, Ljubljana, Slovenia. natalja.fjodorova@ki.si
Abstract:
The aim of this article is to show the main aspects of quantitative structure activity relationship (QSAR) modeling for regulatory purposes. We try to answer the question; what makes QSAR models suitable for regulatory uses. The article focuses on directions in QSAR modeling in European Union (EU) and Russia. Difficulties in validation models have been discussed.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Regulation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Global Regulatory Systems
Quantitative Aspects of Drug-Receptor Interaction
